Exhibit 10.27 Amendment to the Co-Development Agreement between Bioenvision, Inc. and Southern Research Institute WHEREAS Southern Research Institute ("SRI") and Eurobiotech Group, Inc. (now Bioenvision, Inc., through a 100% equity purchase)...Bioenvision Inc • October 13th, 2005 • Pharmaceutical preparations
EXHIBIT 10.14 SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 13th, 2000 • Bioenvision Inc • Non-operating establishments • Delaware
Exhibit 10.21 FORM OF REGISTRATION RIGHTS AGREEMENT Registration Rights Agreement, dated as of May 7, 2002 (this "Agreement"), by and among Bioenvision, Inc., a Delaware corporation (the "Company"), and the Purchasers (as defined below). W I T N E S S...Registration Rights Agreement • May 28th, 2002 • Bioenvision Inc • Pharmaceutical preparations • New York
Exhibit 4.2 FORM OF WARRANT NEITHER THIS WARRANT NOR THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), AND SUCH SECURITIES MAY NOT BE OFFERED, SOLD, TRANSFERRED,...Warrant Agreement • May 28th, 2002 • Bioenvision Inc • Pharmaceutical preparations • New York
Exhibit 10.34 LICENSE AGREEMENT THIS LICENSE AGREEMENT (this "Agreement") is entered into as of September 12, 2006 (the "Effective Date"), by and between SOUTHERN RESEARCH INSTITUTE, having its principal place of business at 2000 Ninth Avenue South,...License Agreement • November 9th, 2006 • Bioenvision Inc • Pharmaceutical preparations • Alabama
JOINT FILING AGREEMENTJoint Filing Agreement • December 17th, 2004 • Bioenvision Inc • Pharmaceutical preparations
Each of the undersigned hereby acknowledges and agrees, in compliance with the provisions of Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, that the Schedule 13D to which this Agreement is attached as an Exhibit (the "Schedule 13D"), and any amendments thereto, will be filed with the Securities and Exchange Commission jointly on behalf of the undersigned. This Agreement may be executed in one or more counterparts.
EXHIBIT 10.13 EMPLOYMENT AGREEMENT THIS AGREEMENT (the "Agreement") is made and effective as of the 1st September 1999, by and between Bioenvision, Inc, a Delaware Corporation (the "Company't), and Christopher Barry Wood MD (the "Executive"). WHEREAS,...Employment Agreement • November 13th, 2000 • Bioenvision Inc • Non-operating establishments • Delaware
Exhibit 4.3 THIS WARRANT HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS OF ANY STATE AND MAY NOT BE SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT OR...Bioenvision Inc • March 25th, 2004 • Pharmaceutical preparations • New York
Exhibit 4.2 REGISTRATION RIGHTS AGREEMENT ----------------------------- This Registration Rights Agreement (the "Agreement") is made and entered into as of this 22nd day of March, 2004, by and among Bioenvision, Inc., a Delaware corporation (the...Registration Rights Agreement • March 25th, 2004 • Bioenvision Inc • Pharmaceutical preparations • New York
EXHIBIT 10.23(a) Amendment No. 1 to License Agreement This Amendment No. 1 is made and entered into as of this 7th day of May, 2002, by and among OKLAHOMA MEDICAL RESEARCH FOUNDATION, an Oklahoma non profit corporation ("OMRF"), 825 N.E. 13th Street,...License Agreement • June 24th, 2002 • Bioenvision Inc • Pharmaceutical preparations
Exhibit 10.20 FORM OF SECURITIES PURCHASE AGREEMENT Securities Purchase Agreement (together with the schedules and exhibits hereto, this "Agreement"), dated as of May 7, 2002, by and between Bioenvision, Inc., a Delaware corporation (the "Company"),...Securities Purchase Agreement • May 28th, 2002 • Bioenvision Inc • Pharmaceutical preparations • New York
LICENSE AGREEMENT THIS AGREEMENT dated 11 March 1999 is between: (1) UNIVERSITY COLLEGE LONDON, incorporated in the United Kingdom by Royal Charter, acting through its Royal Free and University College Medical School, whose address is Rowland Hill...License Agreement • October 18th, 1999 • Bioenvision Inc • Non-operating establishments
BETWEEN BIOENVISION AND ILEX ONCOLOGYDevelopment Agreement • June 24th, 2002 • Bioenvision Inc • Pharmaceutical preparations • Delaware
andMaster Services Agreement • September 29th, 2003 • Bioenvision Inc • Pharmaceutical preparations
WITNESSETHDistribution Agreement • May 15th, 2006 • Bioenvision Inc • Pharmaceutical preparations
EMPLOYMENT AGREEMENT THIS AGREEMENT (the "agreement") is made and effective as of the 15 May 1997, by and between EuroBiotech Group, Inc, a Delaware Corporation (the "Company"), and Stuart Smith (the "Executive"). WHEREAS, the Company desires to...Employment Agreement • October 18th, 1999 • Bioenvision Inc • Non-operating establishments • Delaware
Exhibit 4.1 COMMON STOCK AND WARRANT PURCHASE AGREEMENT ------------------------------------------- THIS COMMON STOCK AND WARRANT PURCHASE AGREEMENT ("Agreement") is made as of this 22 day of March, 2004, by and among Bioenvision, Inc., a Delaware...Common Stock and Warrant Purchase Agreement • March 25th, 2004 • Bioenvision Inc • Pharmaceutical preparations • New York
RESEARCH AGREEMENT (1) BIOENVISION INC. (2) CARDIFF UNIVERSITY THIS AGREEMENT is made the 8 day of July 1999 BETWEEN:- (1) BIOENVISION INC., a Delaware corporation with its main office at Trafalgar House, 11 Waterloo Place, London SW1Y 4AU...Research Agreement • October 18th, 1999 • Bioenvision Inc • Non-operating establishments • England and Wales
EXHIBIT 10.25 Licence agreement THIS AGREEMENT dated 11th March 1999 is between: (1) UNIVERSITY COLLEGE LONDON, incorporated in the United Kingdom by Royal Charter, acting through its Royal Free and University College Medical School, whose address is...Licence Agreement • June 24th, 2002 • Bioenvision Inc • Pharmaceutical preparations
RESEARCH AND DEVELOPMENT AGREEMENT between the Eurobiotech Inc. 712 Fifth Avenue New York NY 10019 USA - hereafter called "The Sponsor" and the Forschungsgesellschaft fur Biomedizinische Technike e. v. - Helmholtz-Institut - Pauwelsstrasse 20 D-52074...Research and Development Agreement • October 18th, 1999 • Bioenvision Inc • Non-operating establishments
2. AWARDSponsored Research Agreement • October 13th, 1999 • Bioenvision Inc • Non-operating establishments • Texas
Exhibit 10.2 GENERAL SERVICES AGREEMENT This General Services Agreement (the "Agreement") is made and effective as of March 25, 2003 ("Effective Date"), by and between RRD International, LLC, a Delaware limited liability company with principal...General Services Agreement • May 15th, 2003 • Bioenvision Inc • Pharmaceutical preparations • Delaware
Exhibit I JOINT FILING AGREEMENT This will confirm the agreement by and among the undersigned that the Schedule 13G filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the...Joint Filing Agreement • March 9th, 2004 • Bioenvision Inc • Pharmaceutical preparations
This will confirm the agreement by and among the undersigned that the Schedule 13G filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the Common Stock, $0.001 par value, of Bioenvision, Inc., a Delaware corporation, is being filed, and all amendments thereto will be filed, on behalf of each of the persons and entities named below in accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.
Letterhead]Bioenvision Inc • October 13th, 2005 • Pharmaceutical preparations
EXHIBIT 10.1 EMPLOYMENT AGREEMENT -------------------- This agreement (the "Agreement) is made and effective as of October 23, 2002, by and between Bioenvision Ltd, a private limited company organized under the laws of the United Kingdom and a wholly...Employment Agreement • November 14th, 2003 • Bioenvision Inc • Pharmaceutical preparations
THIS AGREEMENT is made the_______ day of__________July 1998 BETWEEN; (1) Bioenvision, Inc. whose registered office is at Trafalgar House, 11 Waterloo Place, London SW1Y 4AU (the 'Company') and (2) Thomas Nelson, of Castlefield, Old Park Lane, Farnham,...Agreement • October 13th, 1999 • Bioenvision Inc • Non-operating establishments • England
Exhibit 10.2 EMPLOYMENT AGREEMENT -------------------- THIS AGREEMENT (the "Agreement) is made and effective as of January 6, 2003, by and between Bioenvision Ltd, a private limited company organized under the laws of the United Kingdom and a wholly...Employment Agreement • November 14th, 2003 • Bioenvision Inc • Pharmaceutical preparations
ARTICLE VII ADDITIONAL AGREEMENTS 7.1BEST EFFORTS; COOPERATION; FURTHER ASSURANCES 23 7.2ACCESS TO INFORMATION 23 7.3NOTIFICATION OF CERTAIN MATTERS 23 7.4PUBLICITY 24 7.5EXCLUSIVE DEALINGS 24 7.6TRADING IN PARENT COMMON STOCK 24 7.7EMPLOYEE MATTERS...Amended and Restated Agreement and Plan of Merger • April 16th, 2002 • Bioenvision Inc • Pharmaceutical preparations • New York
Exhibit 1.1 BIOENVISION, INC. 7,500,000 Shares of Common Stock Underwriting Agreement ----------------------Bioenvision Inc • February 3rd, 2005 • Pharmaceutical preparations • New York
I. ARTICLE DEFINITIONSRegistration Rights Agreement • May 15th, 2003 • Bioenvision Inc • Pharmaceutical preparations • New York
FORM OF REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (the "Agreement") is made by and among Bioenvision, Inc. (the "Company") and each SHAREHOLDER executing a copy hereof (collectively, the "Shareholders," and each a...Form of Registration Rights Agreement • April 16th, 2002 • Bioenvision Inc • Pharmaceutical preparations • New York
andRights Agreement • November 18th, 2004 • Bioenvision Inc • Pharmaceutical preparations • New York
EXHIBIT 10.27 RESEARCH and LICENCE AGREEMENT (1) BIOENVISION INC.Research and Licence Agreement • June 24th, 2002 • Bioenvision Inc • Pharmaceutical preparations
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • April 2nd, 2007 • Bioenvision Inc • Pharmaceutical preparations • New York
of a financial, statistical or accounting nature included or incorporated by reference therein, as to which we express no opinion), complied as to form in all material respects with the applicable requirements of Form 10-K, Form 10-Q and Form 8-K, as the case may be, under the Securities Exchange Act of 1934, as amended;
SUPPLY AGREEMENT - TRILOSTANE STEROID SpA page 1 of 20Supply Agreement • November 14th, 2005 • Bioenvision Inc • Pharmaceutical preparations
